​

Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?

OverviewForecastRevenueFinancialsChartTranscripts

Arbutus Biopharma Ownership Summary

Arbutus Biopharma is owned by 53.32% institutional investors, 22.22% insiders, and 24.46% retail investors. Morgan stanley is the largest institutional shareholder, holding 11.93% of ABUS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.

ABUS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArbutus Biopharma53.32%22.22%24.46%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley20.96M11.93%$64.77M
Whitefort capital management, lp12.87M7.33%$39.76M
Blackrock11.55M6.58%$35.70M
Two seas capital lp8.57M4.88%$26.49M
Vanguard group7.02M4.00%$21.70M
Geode capital management3.31M1.89%$10.24M
Adar1 capital management3.29M1.87%$10.16M
Adage capital partners gp3.00M1.71%$9.27M
State street2.93M1.67%$9.07M
Blackbarn capital partners lp2.07M1.18%$6.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Whitefort capital management, lp12.87M24.51%$39.76M
Two seas capital lp8.57M4.30%$26.49M
Corbin capital partners853.30K4.25%$2.20M
Fourworld capital management1.57M2.91%$4.85M
Adar1 capital management3.29M1.92%$10.16M
Blackbarn capital partners lp2.07M0.57%$6.40M
Rubric capital management lp1.68M0.14%$5.19M
Freestone capital546.25K0.06%$1.69M
Quinn opportunity partners165.13K0.06%$510.26K
Boothbay fund management612.28K0.04%$1.89M

Top Buyers

HolderShares% AssetsChange
Morgan stanley20.96M0.01%12.13M
Rubric capital management lp1.68M0.14%1.68M
Adar1 capital management3.29M1.92%1.22M
Blackrock11.55M0.00%1.15M
Vanguard group7.02M0.00%1.03M

Top Sellers

HolderShares% AssetsChange
Woodline partners lp926.53K0.03%-3.14M
Hudson bay capital management lp1.69M0.02%-1.84M
American century companies18.49K--107.73K
Centiva capital, lp---102.20K
Lmr partners llp---100.00K

New Positions

HolderShares% AssetsChangeValue
Rubric capital management lp1.68M0.14%1.68M$5.19M
Freestone capital546.25K0.06%546.25K$1.69M
Quinn opportunity partners165.13K0.06%165.13K$510.26K
Mitsubishi ufj kokusai asset management89.69K0.00%89.69K$277.16K
Corebridge financial75.04K0.00%75.04K$231.87K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-24.00
Central trust-100.00
Opal wealth advisors-100.00
Financial synergies wealth advisors-3.60K
Fny investment advisers-3.80K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202415312.50%100,767,7004.58%532.03%778.45%313.33%
Jun 30, 20241355.47%96,359,00316.04%542.19%7126.79%30-6.25%
Mar 31, 20241284.92%83,042,4715.67%502.27%567.69%3214.29%
Dec 31, 202312215.09%78,586,63311.02%462.58%5233.33%2816.67%
Sep 30, 2023106-10.17%70,787,8206.95%422.54%39-20.41%24-22.58%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.87M2.57%-
iShares Russell 2000 ETF3.98M2.10%-15.30K
Morgan Stanley Insight A3.85M2.03%-392.53K
Morgan Stanley Insight3.85M2.03%-392.53K
MS INVF Global Insight Z2.50M1.32%322.08K
Vanguard Institutional Extnd Mkt Idx Tr2.22M1.17%-151.50K
Morgan Stanley Inst Inception I2.20M1.16%-221.83K
Morgan Stanley Inception2.20M1.16%-221.83K
EQ/Morgan Stanley Small Cap Growth K1.78M0.94%-
SPDR® S&P Biotech ETF1.67M0.88%-19.54K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 14, 2024MANCHESTER KEITH S-Sell$32.64K
Feb 02, 2024Sims Karen Chief Medical OfficerSell$10.08K
Feb 02, 2024HASTINGS DAVID C Chief Financial OfficerSell$22.18K
Feb 02, 2024Sofia Michael J. Chief Scientific OfficerSell$23.08K
Feb 02, 2024McElhaugh Michael J. Interim President & CEOSell$23.50K

Insider Transactions Trends

DateBuySell
2024 Q3-1
2024 Q2--
2024 Q1-4
2023 Q3--
2023 Q2--

ABUS Ownership FAQ

Who Owns Arbutus Biopharma?

Arbutus Biopharma shareholders are primarily institutional investors at 53.32%, followed by 22.22% insiders and 24.46% retail investors. The average institutional ownership in Arbutus Biopharma's industry, Biotech Stocks , is 109.70%, which Arbutus Biopharma falls below.

Who owns the most shares of Arbutus Biopharma?

Arbutus Biopharma’s largest shareholders are Morgan stanley (20.96M shares, 11.93%), Whitefort capital management, lp (12.87M shares, 7.33%), and Blackrock (11.55M shares, 6.58%). Together, they hold 25.84% of Arbutus Biopharma’s total shares outstanding.

Does Blackrock own Arbutus Biopharma?

Yes, BlackRock owns 6.58% of Arbutus Biopharma, totaling 11.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.7M$. In the last quarter, BlackRock increased its holdings by 1.15M shares, a 11.03% change.

Who is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested?

Whitefort capital management, lp is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested, with 24.51% of its assets in 12.87M Arbutus Biopharma shares, valued at 39.76M$.

Who is the top mutual fund holder of Arbutus Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Arbutus Biopharma shares, with 2.57% of its total shares outstanding invested in 4.87M Arbutus Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools